Article Information
Published By
Online ISSN
History
- Received January 3, 2023
- Accepted January 3, 2023
- Published online March 9, 2023.
Article Versions
- You are currently viewing a previous version of this article (March 9, 2023 - 07:24).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2023 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Johannes A. Kroes1⇑,
- Rafael Alfonso-Cristancho2,
- Aruna T. Bansal3,
- Emmanuelle Berret4,
- Kristina Bieksiene5,
- Arnaud Bourdin6,
- Luisa Brussino7,
- Diogo Canhoto8,
- Cristina Cardini9,
- Gulfem Celik10,
- Zsuzsanna Csoma11,
- Barbro Dahlén12,
- Ebru Damadoglu13,
- Katrien Eger14,
- Lisa Gauquelin15,
- Bilun Gemicioglu16,
- Ozlem Goksel17,
- Sophie Graff18,
- Enrico Heffler19,20,
- Hendrik B. Hofstee21,
- Peter Howarth22,
- Rupert W. Jakes22,
- Fabienne Jaun23,
- Virginija Kalinauskaite-Zukauske5,
- Peter Kopač24,25,
- Namhee Kwon22,
- Claudia C. Loureiro26,
- Victor Lozoya García27,
- Matthew Masoli28,
- Mariana Paula Rezelj24,
- Luis Pérez De Llano29,
- Sanja Popović-Grle30,
- David Ramos-Barbon31,
- Ana Sà Sousa32,
- Konstantinos Samitas33,
- Florence Schleich18,34,
- Concetta Sirena9,
- Sabina Skrgat25,35,
- Eleftherios Zervas33,
- George Zichnalis36,
- Elisabeth H. Bel14,
- Jacob K. Sont21,
- Simone Hashimoto14 and
- Anneke Ten Brinke1
- 1Medical Centre Leeuwarden, Leeuwarden, Netherlands
- 2GlaxoSmithKline, Collegeville, PA, USA
- 3Acclarogen Ltd, St John's Innovation Centre, Cambridge, United Kingdom
- 4European Respiratory Society (ERS), Lausanne, Switzerland
- 5Lithuanian University of Health Sciences, Kaunas, Lithuania
- 6University of Montpellier, Montpellier, France
- 7University of Turin, Turin, Italy
- 8University of Coimbra, Coimbra, Portugal
- 9Severe Asthma Network in Italy (SANI), Milan, Italy
- 10Ankara University School of Medicine, Ankara, Turkey
- 11National Koranyi Institute for Pulmonology, Budapest, Hungary
- 12Karolinska Institutet, Stockholm, Sweden
- 13Hacettepe University Faculty of Medicine, Ankara, Turkey
- 14University of Amsterdam, Amsterdam, Netherlands
- 15AP-HP.Sorbonne Université, Hôpital Pitié Salpêtrière, Paris, France
- 16Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey
- 17Ege University, Faculty of Medicine, Izmir, Turkey
- 18University of Liege, Liege, Belgium
- 19IRCCS Humanitas Research Hospital, Rozzano, MI, Italy
- 20Humanitas University, Pieve Emanuele, MI, Italy
- 21Leiden University Medical Centre, Leiden, Netherlands
- 22GlaxoSmithKline, Brentford, United Kingdom
- 23Cantonal Hospital Baselland, Liestal, Switzerland
- 24University Clinic of Respiratory Diseases Golnik, Golnik, Slovenia
- 25Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
- 26Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
- 27Evidenze Clinical Research, Madrid, Spain
- 28The Royal Devon & Exeter Hospital, Exeter, United Kingdom
- 29Pneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Monforte, Cervo, Spain
- 30University Hospital Centre Zagreb, Zagreb, Croatia
- 31Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- 32Universidade do Porto, Porto, Portugal
- 33Athens Chest Hospital, Athens, Greece
- 34GIGA I3, Liege, Belgium
- 35University Medical Centre Ljubljana, Ljubljana, Slovenia
- 36LogicOne, Athens, Greece
- Corresponding author: Johannes Kroes (j.a.kroes{at}rug.nl)
Funding
GlaxoSmithKline
Study identifier: 212821
Article usage
Altmetrics
Vol 9 Issue 3
Table of Contents
Evaluation of Real-World Mepolizumab Use in Severe Asthma across Europe - the SHARP experience with privacy-preserving federated analysis
